Overview
- 189 inspections across 176 sites are on record.
- 125 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-06-12.
At a glance
Inspections
189
Sites
176
Observations
125
Career since
Mar 2013
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Roueen Rafeyan, M.D. | 12 Jun 2026 | Human Drugs | |
| Marjo S. van der Knaap, MD, PhD | 15 May 2026 | Human Drugs | |
| Antonio Gil-Nagel, MD, PhD | 8 May 2026 | Human Drugs | |
| Jorge E. Lopera, M.D. | 16 Apr 2026 | Medical Devices & Rad Health | |
| AbbVie Inc. | 2 Apr 2026 | Human Drugs |
Sites inspected
Roueen Rafeyan, M.D.Chicago, United States1 insp.
Marjo S. van der Knaap, MD, PhDAmsterdam, Netherlands1 insp.
Antonio Gil-Nagel, MD, PhDMadrid, Spain1 insp.
Jorge E. Lopera, M.D.San Antonio, United States1 insp.
AbbVie Inc.North Chicago, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Jeanne J Chiu28 shared
Colleen E Burke20 shared
Yuanyuan Li15 shared
Vidhi J Jani5 shared
Debra L Boyd Seale5 shared
Rachel E Mcguigan3 shared
Dustin P Tran3 shared
Adam J Taylor3 shared
Muhammad Naiman2 shared
Linh Tu2 shared
Full investigator report
Get the verbatim findings behind Jeanne J Thai's 125 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site